SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-012574
Filing Date
2023-05-04
Accepted
2023-05-04 16:15:35
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20230331_10q.htm   iXBRL 10-Q 576145
2 EXHIBIT 31.1 ex_510239.htm EX-31.1 13402
3 EXHIBIT 31.2 ex_510238.htm EX-31.2 12356
4 EXHIBIT 32.1 ex_510237.htm EX-32.1 4662
5 EXHIBIT 32.2 ex_510236.htm EX-32.2 4917
  Complete submission text file 0001437749-23-012574.txt   3215465

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20230331.xsd EX-101.SCH 33462
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20230331_cal.xml EX-101.CAL 22320
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20230331_def.xml EX-101.DEF 212603
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20230331_lab.xml EX-101.LAB 207102
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20230331_pre.xml EX-101.PRE 231532
42 EXTRACTED XBRL INSTANCE DOCUMENT pbla20230331_10q_htm.xml XML 361302
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 23888938
SIC: 2834 Pharmaceutical Preparations